Ignite Creation Date:
2024-05-05 @ 5:20 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00437255
Status:
COMPLETED
Last Update Posted:
2022-07-29
First Post:
2007-02-16
Brief Title:
Efficacy Safety Preference and Response Duration of Clobex Spray and Taclonex Ointment in Psoriasis
Sponsor:
Galderma RD
Organization:
Galderma RD
Study Overview
Official Title:
An Evaluation of the Efficacy Safety Preference and Duration of Response of Clobex Clobetasol Propionate Spray and Taclonex Calcipotriene 005Betamethasone Dipropionate 0064 Ointment in Subjects With Stable Plaque Psoriasis
Status:
COMPLETED
Status Verified Date:
2008-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Evaluate the efficacy of Clobex Spray as compared to Taclonex Ointment in terms of Overall Disease Severity and Investigator Global Assessment
Detailed Description:
Same as above
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None